Pioglitazone Tablets USP, 45 mg, 500 count bottles, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ -- NDC 57237-221-05
Recall Number: D-0450-2022
Firm: Aurobindo Pharma USA Inc.
Classification: Class II
Status: Terminated
Report Date: 20220202
Initiation Date: 20211229
Termination Date: 20231204
Reason for Recall
Superpotent and Failed Tablet/Capsule Specifications
Product Description
Pioglitazone Tablets USP, 45 mg, 500 count bottles, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ -- NDC 57237-221-05